Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1992;23:1826-1839

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wardlaw, J. M.
Right arrow Articles by Warlow, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wardlaw, J. M.
Right arrow Articles by Warlow, C. P.

Stroke, Vol 23, 1826-1839, Copyright © 1992 by American Heart Association


ARTICLES

Thrombolysis in acute ischemic stroke: does it work?

JM Wardlaw and CP Warlow
Department of Clinical Neurosciences, Western General Hospital, Edinburgh, UK.

BACKGROUND: This article is presented to provoke further discussion regarding the use of thrombolytic drugs to treat acute ischemic stroke. SUMMARY OF REVIEW: Overview analysis of the six randomized trials of thrombolysis in acute ischemic stroke available in the world literature shows a 20% increase in the odds of death and a 30% reduction in the odds of death or deterioration (both with wide confidence intervals, neither result significant) after thrombolytic treatment for acute ischemic stroke. Exclusion of the two trials conducted without the benefit of computed tomographic scanning shows a 37% reduction in the odds of death (95% confidence interval, 74% reduction to 40% excess) and a significant reduction of 56% in the odds of death or deterioration after thrombolytic treatment (95% confidence interval, 20- 76% reduction; 2p = 0.007). Analysis of all published studies (randomized and nonrandomized) shows that there does not appear to be an excess risk of hemorrhagic transformation of the cerebral infarct or of severe edema formation. CONCLUSIONS: We believe the present evidence is sufficiently encouraging to warrant proper testing of thrombolysis in sufficiently large and well-designed randomized clinical trials to influence clinical practice.


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
R.M. Sugg, E.A. Noser, H.M. Shaltoni, N.R. Gonzales, M.S. Campbell, R. Weir, E.D. Cacayorin, and J.C. Grotta
Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke.
AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 769 - 773.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K.R. Lees, D. Barer, G.A. Ford, W. Hacke, V. Kostulas, A.K. Sharma, and T. Odergren
Tolerability of NXY-059 at Higher Target Concentrations in Patients With Acute Stroke
Stroke, February 1, 2003; 34(2): 482 - 487.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Nakano, T. Iseda, T. Yoneyama, H. Kawano, and S. Wakisaka
Direct Percutaneous Transluminal Angioplasty for Acute Middle Cerebral Artery Trunk Occlusion: An Alternative Option to Intra-arterial Thrombolysis
Stroke, December 1, 2002; 33(12): 2872 - 2876.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
W. F. Baker Jr
Thrombolytic Therapy
Clinical and Applied Thrombosis/Hemostasis, October 1, 2002; 8(4): 291 - 314.
[PDF]


Home page
Am. J. Neuroradiol.Home page
T. Yoneyama, S. Nakano, H. Kawano, T. Iseda, T. Ikeda, T. Goya, and S. Wakisaka
Combined Direct Percutaneous Transluminal Angioplasty and Low-Dose Native Tissue Plasminogen Activator Therapy for Acute Embolic Middle Cerebral Artery Trunk Occlusion
AJNR Am. J. Neuroradiol., February 1, 2002; 23(2): 277 - 281.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. M. Wardlaw
Overview of Cochrane thrombolysis meta-analysis
Neurology, September 1, 2001; 57(90002): S69 - 76.
[Abstract] [Full Text]


Home page
NeurologyHome page
G. W. Albers
Advances in intravenous thrombolytic therapy for treatment of acute stroke
Neurology, September 1, 2001; 57(90002): S77 - 81.
[Abstract] [Full Text]


Home page
ChestHome page
G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Chest, January 1, 2001; 119(1_suppl): 300S - 320S.
[Full Text] [PDF]


Home page
Arch NeurolHome page
J. A. Hinchey and C. Benesch
Thrombolytic Therapy in Patients With Acute Ischemic Stroke
Arch Neurol, October 1, 2000; 57(10): 1430 - 1436.
[Full Text] [PDF]


Home page
Arch NeurolHome page
K. H. Lee, S. J. Lee, S.-J. Cho, D. G. Na, H. S. Byun, Y.-B. Kim, H.-J. Song, I.-S. Jin, and C.-S. Chung
Usefulness of Triphasic Perfusion Computed Tomography for Intravenous Thrombolysis With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke
Arch Neurol, July 1, 2000; 57(7): 1000 - 1008.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. W. Albers
Expanding the Window for Thrombolytic Therapy in Acute Stroke : The Potential Role of Acute MRI for Patient Selection
Stroke, October 1, 1999; 30(10): 2230 - 2237.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
M. Davis and D. Barer
Neuroprotection in acute ischaemic stroke. II: Clinical potential
Vascular Medicine, August 1, 1999; 4(3): 149 - 163.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. Jahan, G. R. Duckwiler, C. S. Kidwell, J. W. Sayre, Y. P. Gobin, J. PabloVillablanca, J. Saver, S. Starkman, N. Martin, and F. Vinuela
Intraarterial Thrombolysis for Treatment ofAcute Stroke: Experience in 26 Patients withLong-Term Follow-up
AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1291 - 1299.
[Abstract] [Full Text]


Home page
RadiologyHome page
N. J. Beauchamp Jr, P. B. Barker, P. Y. Wang, and P. C. M. vanZijl
Imaging of Acute Cerebral Ischemia
Radiology, August 1, 1999; 212(2): 307 - 324.
[Abstract] [Full Text]


Home page
StrokeHome page
T. F. Choudhri, B. L. Hoh, R. A. Solomon, E. S. Connolly Jr, and D. J. Pinsky
Use of a Spectrophotometric Hemoglobin Assay to Objectively Quantify Intracerebral Hemorrhage in Mice
Stroke, November 1, 1997; 28(11): 2296 - 2302.
[Abstract] [Full Text]


Home page
CirculationHome page
H. P. Adams, T. G. Brott, A. J. Furlan, C. R. Gomez, J. Grotta, C. M. Helgason, T. Kwiatkowski, P. D. Lyden, J. R. Marler, J. Torner, et al.
Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
Circulation, September 1, 1996; 94(5): 1167 - 1174.
[Full Text]


Home page
NEJMHome page
The Multicenter Acute Stroke Trial -- Europe Study
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
N. Engl. J. Med., July 18, 1996; 335(3): 145 - 150.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. von Kummer, R. Holle, L. Rosin, M. Forsting, and W. Hacke
Does Arterial Recanalization Improve Outcome in Carotid Territory Stroke?
Stroke, April 1, 1995; 26(4): 581 - 587.
[Abstract] [Full Text]


Home page
StrokeHome page
Z. Nagy, K. Kolev, E. Csonka, M. Pek, and R. Machovich
Contraction of Human Brain Endothelial Cells Induced by Thrombogenic and Fibrinolytic Factors : An In Vitro Cell Culture Model
Stroke, February 1, 1995; 26(2): 265 - 270.
[Abstract] [Full Text]